Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4535 USD | -0.63% | -5.52% | -35.31% |
May. 10 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 21 | Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors | CI |
Financials (USD)
Sales 2022 | 1.68M | Sales 2023 | 1.93M | Capitalization | 822M |
---|---|---|---|---|---|
Net income 2022 | -105M | Net income 2023 | -62M | EV / Sales 2022 | 505 x |
Net Debt 2022 | 19.29M | Net Debt 2023 | 43.43M | EV / Sales 2023 | 448 x |
P/E ratio 2022 |
-7.59
x | P/E ratio 2023 |
-11.7
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 90.82% |
1 day | -0.63% | ||
1 week | -5.52% | ||
Current month | -2.47% | ||
1 month | -3.94% | ||
3 months | -17.77% | ||
6 months | -38.17% | ||
Current year | -35.31% |
Managers | Title | Age | Since |
---|---|---|---|
Linda Powers
CEO | Chief Executive Officer | 68 | 07-05-16 |
Alton Boynton
FOU | Founder | 79 | 96-03-17 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 65 | 99-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alton Boynton
FOU | Founder | 79 | 96-03-17 |
Linda Powers
CEO | Chief Executive Officer | 68 | 07-05-16 |
Navid Malik
BRD | Director/Board Member | 55 | 12-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 0.4535 | -0.63% | 843 661 |
24-05-22 | 0.4564 | -0.47% | 2,880,431 |
24-05-21 | 0.4585 | -0.11% | 1,289,166 |
24-05-20 | 0.459 | -1.40% | 1,953,294 |
24-05-17 | 0.4655 | -3.02% | 1,145,477 |
Delayed Quote OTC Markets, May 23, 2024 at 11:16 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-35.31% | 553M | |
+10.47% | 115B | |
+12.77% | 106B | |
-4.06% | 24.69B | |
-2.59% | 21.97B | |
-6.03% | 19.27B | |
-11.38% | 17.56B | |
-39.36% | 17.32B | |
+6.60% | 14.03B | |
+32.54% | 12.13B |
- Stock Market
- Equities
- NWBO Stock